Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ephraim J Fuchs

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
Urology|September 18, 2009
Cryoimmunotherapy in urologic oncologyAbhinav Sidana, Wasim H Chowdhury, Ephraim J Fuchs, et al.
Journal of Hematology & Oncology|April 14, 2016
How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?Ying-Jun Chang, Leo Luznik, Ephraim J Fuchs, et al.
Seminars in Hematology|March 23, 2016
Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamideTara M Robinson, Paul V O'Donnell, Ephraim J Fuchs, et al.
Pediatric Blood & Cancer|September 25, 2004
Bone marrow transplantation for sickle cell anemia: progress and prospectsRobert Iannone, Kwaku Ohene-Frempong, Ephraim J Fuchs, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 28, 2014
Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignanciesMary Eapen, Paul O'Donnell, Claudio G Brunstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2006
Host-derived Langerhans cells persist after MHC-matched allografting independent of donor T cells and critically influence the alloresponses mediated by donor lymphocyte infusionsNadira Durakovic, Karl B Bezak, Mario Skarica, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2009
Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantationHeather J Symons, M Sue Leffell, Nancy D Rossiter, et al.
Journal of Comparative Effectiveness Research|March 21, 2014
Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancerJoshua A Roth, Mark E Bensink, Paul V O'Donnell, et al.
Blood|January 18, 2007
Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouseNadira Durakovic, Vedran Radojcic, Mario Skarica, et al.
Pediatric Reports|November 5, 2011
Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamideAshley Munchel, Chimen Kesserwan, Heather J Symons, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
Urology|September 18, 2009
Cryoimmunotherapy in urologic oncologyAbhinav Sidana, Wasim H Chowdhury, Ephraim J Fuchs, et al.
Journal of Hematology & Oncology|April 14, 2016
How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?Ying-Jun Chang, Leo Luznik, Ephraim J Fuchs, et al.
Seminars in Hematology|March 23, 2016
Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamideTara M Robinson, Paul V O'Donnell, Ephraim J Fuchs, et al.
Pediatric Blood & Cancer|September 25, 2004
Bone marrow transplantation for sickle cell anemia: progress and prospectsRobert Iannone, Kwaku Ohene-Frempong, Ephraim J Fuchs, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 28, 2014
Mismatched related and unrelated donors for allogeneic hematopoietic cell transplantation for adults with hematologic malignanciesMary Eapen, Paul O'Donnell, Claudio G Brunstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2006
Host-derived Langerhans cells persist after MHC-matched allografting independent of donor T cells and critically influence the alloresponses mediated by donor lymphocyte infusionsNadira Durakovic, Karl B Bezak, Mario Skarica, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 8, 2009
Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantationHeather J Symons, M Sue Leffell, Nancy D Rossiter, et al.
Journal of Comparative Effectiveness Research|March 21, 2014
Design of a cost-effectiveness analysis alongside a randomized trial of transplantation using umbilical cord blood versus HLA-haploidentical related bone marrow in advanced hematologic cancerJoshua A Roth, Mark E Bensink, Paul V O'Donnell, et al.
Blood|January 18, 2007
Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouseNadira Durakovic, Vedran Radojcic, Mario Skarica, et al.
Pediatric Reports|November 5, 2011
Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamideAshley Munchel, Chimen Kesserwan, Heather J Symons, et al.
Pageof 12